BioLineRx Ltd. (NASDAQ: BLRX) and Hemispherian AS announced that two abstracts on their GLIX1 compound have been accepted for presentation ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE